SouthState Corp’s Idexx Laboratories IDXX Stock Holding History

SouthState Corp’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.74K	Sell	9 -3	-25%	-$1.68K	﹤0.01%	808
2026 Q1	$6.74K	Sell	12 -140	-92%	-$89.8K	﹤0.01%	722
2025 Q4	$103K	Sell	152 -4	-3%	-$2.72K	﹤0.01%	378
2025 Q3	$99.7K	Sell	156 -7	-4%	-$4.25K	﹤0.01%	382
2025 Q2	$87.4K	Sell	163 -19	-10%	-$9.09K	﹤0.01%	438
2025 Q1	$76.4K	Buy	+182	New	+$79K	﹤0.01%	470
2024 Q2	–	Sell	-208	Closed	-$112K	–	704
2024 Q1	$112K	Buy	+208	New	+$114K	0.01%	290
2022 Q1	–	Sell	-4	Closed	-$3K	–	737
2021 Q4	$3K	Buy	+4	New	+$2.51K	﹤0.01%	661

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

SouthState Corp's IDXX Position: Q2 2026 in Review

SouthState Corp reduced its Idexx Laboratories (IDXX) stake by 25% in Q2 2026, selling an estimated $1.68K and leaving 9 shares worth $4.74K. The position accounts for ﹤0.01% of the portfolio, ranked #808.

SouthState Corp first reported a position in IDXX in Q4 2021 and has held it in 8 quarters since. The position peaked at $112K in Q1 2024. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

SouthState Corp held 9 shares of Idexx Laboratories worth $4.74K as of Q2 2026.
SouthState Corp sold 3 Idexx Laboratories shares in Q2 2026, an estimated $1.68K.
Idexx Laboratories made up ﹤0.01% of SouthState Corp's portfolio in Q2 2026, its #808 holding.
SouthState Corp first reported a position in Idexx Laboratories in Q4 2021 and has held it in 8 quarters since.
SouthState Corp's Idexx Laboratories position peaked at $112K in Q1 2024.
1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on SouthState Corp's 13F filing for Q2 2026, filed 6 Aug 2026.